N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial
- Resource Type
- Article
- Source
- In
Contemporary Clinical Trials November 2022 122 - Subject
- Language
- ISSN
- 1551-7144